Furthermore, these results show that in prostate cancer, cav-2 was not associated with caveolae as while PTRF and caveolae were lost in PC3 and CaP tissue, cav-2 expression remained unchanged. The gene discussed is CAVIN1; the disease is prostate carcinoma.